$\require{mediawiki-texvc}$
  • 검색어에 아래의 연산자를 사용하시면 더 정확한 검색결과를 얻을 수 있습니다.
  • 검색연산자
검색연산자 기능 검색시 예
() 우선순위가 가장 높은 연산자 예1) (나노 (기계 | machine))
공백 두 개의 검색어(식)을 모두 포함하고 있는 문서 검색 예1) (나노 기계)
예2) 나노 장영실
| 두 개의 검색어(식) 중 하나 이상 포함하고 있는 문서 검색 예1) (줄기세포 | 면역)
예2) 줄기세포 | 장영실
! NOT 이후에 있는 검색어가 포함된 문서는 제외 예1) (황금 !백금)
예2) !image
* 검색어의 *란에 0개 이상의 임의의 문자가 포함된 문서 검색 예) semi*
"" 따옴표 내의 구문과 완전히 일치하는 문서만 검색 예) "Transform and Quantization"
쳇봇 이모티콘
안녕하세요!
ScienceON 챗봇입니다.
궁금한 것은 저에게 물어봐주세요.

논문 상세정보

Abstract

This study was conducted to investigate the subacute intravenous toxicity of rHu-EPO in Sprague-Dawley rats. rHu-EPO was daily administered to male and female rats for 30 days with different dose levels(100, 500, 2,500 unit/ kg). After the administration period of 30 days, 5 males and 5females rats per each dose group were assigned for recovery period of additional 30 days. There were no clinical signs compared with control group but slight decrease in spontaneous motor activities and locomotions were observed at high dose groups of males and females. In males, feed consumption was reduced at 500 unit/kg and body weight gain was retarded. In the administration sites of tail, focal congestion was observed in a few animals treated with rHu-EPO. No deaths were occurred during the course of study. In hematological examination. a significant increase of hemoglobin and hematocrit was observed in the males and females rats receiving high dose of rHu-EPO. rHu-EPO administration for 30 days showed a marked decrease in glucose concentration. At the highest dose groups, there was a significant incerase in the weights of spleens in both sexes. but this was considered to be related to its pharmacological activity. These results indicate that rHu-EPO does not induce any significant toxic effect on Sprague-Dawley rats for 30 days.

참고문헌 (10)

  1. Characterization of recombinant human erythropoietin production in Chinese hamster ovary cells , Davis,J.M.;Arakawa,R.;Strickland,T.W.;Yphantis,D.A. , Biochemistry / v.26,pp.2633-2638, 1987
  2. Renal and extrarenal erythropoietin production in anaemic rats , Erslev,A.J.;Caro,J.;Kansu,E.;Silver,R. , Br. J. Haematol. / v.45,pp.65-72, 1980
  3. The quality of life of hemodialysis recipients treated with recombinant human erythropoietin , Evans,R.W.;Rader,B.;Manninen,D.L.;the Cooperative Multicenter EPO Clinical Trial Group , JAMA / v.263,pp.825-830, 1990
  4. Recent advances in erythropoietin research , Fisher,J.W.;Ernst Jucker(ed.) , Progress in Drug Research / v.41,pp.293-311, 1993
  5. Subacute toxicity of recombinant human erythropoietin in rats , Kim,D.H.;Lim,D.M.L.;Cho,H.J.;Park,K.H.;Ha,B.J.;Kim,H.S. , Korean J. Toxicol. / v.10,pp.243-254, 1994
  6. A new approach to practical toxicity testing , Lorke,D. , Arch. Toxicol. / v.54,pp.275-287, 1983
  7. General Pharmacological studies of erythropoietin(TYB-5220) , Mino,T.;Ohmura,T.;Hiraoka,Y.;Sugino,T.;Hayashi,H. , 藥理と治療 / v.18,pp.953-971, 1990
  8. National Institute of Safety Research , Toxicity test guideline for safety evaluation of drugs for human use, No. 94-3 Korea / v.,pp., 1994
  9. Acute subcutaneous and intravenous toxicity studies in rats and monkeys with TYB-5220 , Spicer,E.J.F.;Wisler,J.A. , 藥理と治療 / v.18,pp.973-1034, 1990
  10. Treatment of the anemia of chronic renal falure with recombinant human erythropoietin , Wineals,C.G. , Drugs / v.38,pp.342-345, 1988

이 논문을 인용한 문헌 (0)

  1. 이 논문을 인용한 문헌 없음

원문보기

원문 PDF 다운로드

  • ScienceON :

원문 URL 링크

원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다. (원문복사서비스 안내 바로 가기)

상세조회 0건 원문조회 0건

DOI 인용 스타일